Shi Q - Search Results

1

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Bao S, et al. Among authors: shi q. Nature. 2006 Dec 7;444(7120):756-60. doi: 10.1038/nature05236. Epub 2006 Oct 18. Nature. 2006. PMID: 17051156

2

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Bao S, et al. Among authors: shi q. Cancer Res. 2006 Aug 15;66(16):7843-8. doi: 10.1158/0008-5472.CAN-06-1010. Cancer Res. 2006. PMID: 16912155

3

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN. Li Z, et al. Among authors: shi q. Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018. Cancer Cell. 2009. PMID: 19477429 Free PMC article.

4

Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, Bigner DD, Counter CM, Wang XF. Rich JN, et al. Among authors: shi q. J Biol Chem. 2003 May 2;278(18):15951-7. doi: 10.1074/jbc.M211498200. Epub 2003 Feb 17. J Biol Chem. 2003. PMID: 12590137 Free article.

5

Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.

Shi Q, Bao S, Maxwell JA, Reese ED, Friedman HS, Bigner DD, Wang XF, Rich JN. Shi Q, et al. J Biol Chem. 2004 Dec 10;279(50):52200-9. doi: 10.1074/jbc.M409630200. Epub 2004 Oct 5. J Biol Chem. 2004. PMID: 15469933 Free article.

6

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.

Goudar RK, Shi Q, Hjelmeland MD, Keir ST, McLendon RE, Wikstrand CJ, Reese ED, Conrad CA, Traxler P, Lane HA, Reardon DA, Cavenee WK, Wang XF, Bigner DD, Friedman HS, Rich JN. Goudar RK, et al. Among authors: shi q. Mol Cancer Ther. 2005 Jan;4(1):101-12. Mol Cancer Ther. 2005. PMID: 15657358

7

Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.

Hjelmeland AB, Hjelmeland MD, Shi Q, Hart JL, Bigner DD, Wang XF, Kontos CD, Rich JN. Hjelmeland AB, et al. Among authors: shi q. Cancer Res. 2005 Dec 15;65(24):11276-81. doi: 10.1158/0008-5472.CAN-05-3016. Cancer Res. 2005. PMID: 16357132

8

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.

Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, Ohmori O, Bigner DD, Friedman HS, Rich JN. Shi Q, et al. Mol Carcinog. 2007 Jun;46(6):488-96. doi: 10.1002/mc.20297. Mol Carcinog. 2007. PMID: 17219439

9

The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion.

Hjelmeland AB, Lattimore KP, Fee BE, Shi Q, Wickman S, Keir ST, Hjelmeland MD, Batt D, Bigner DD, Friedman HS, Rich JN. Hjelmeland AB, et al. Among authors: shi q. Mol Cancer Ther. 2007 Sep;6(9):2449-57. doi: 10.1158/1535-7163.MCT-07-0155. Epub 2007 Aug 31. Mol Cancer Ther. 2007. PMID: 17766837

10

Targeting A20 decreases glioma stem cell survival and tumor growth.

Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, Lathia JD, Macswords J, Lee J, McLendon RE, Rich JN. Hjelmeland AB, et al. Among authors: shi q. PLoS Biol. 2010 Feb 23;8(2):e1000319. doi: 10.1371/journal.pbio.1000319. PLoS Biol. 2010. PMID: 20186265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,927 results

Search Page